Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Drug Delivery and Translational Research|July 1, 2015
Microneedles: an innovative platform for gene deliveryJoanne McCaffrey, Ryan F Donnelly, Helen O McCarthy
Cancer Nanotechnology|July 11, 2015
DNA vaccination for prostate cancer: key concepts and considerationsGrace Cole, Joanne McCaffrey, Ahlam A Ali, et al.
Journal of the American Academy of Dermatology|July 5, 2020
Evaluating the effect of prior authorizations in patients with complex dermatologic conditionsOlivia S Jew, Joyce Okawa, John S Barbieri, et al.
Human Vaccines & Immunotherapeutics|November 16, 2016
Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexationGrace Cole, Joanne McCaffrey, Ahlam A Ali, et al.
Veterinary Immunology and Immunopathology|June 20, 2019
Toll-like receptor agonists as adjuvants for inactivated porcine reproductive and respiratory syndrome virus (PRRSV) vaccineSandra Vreman, Joanne McCaffrey, Ditta J Popma-de Graaf, et al.
Molecular Therapy. Nucleic Acids|March 23, 2017
Systemic RALA/iNOS Nanoparticles: A Potent Gene Therapy for Metastatic Breast Cancer Coupled as a Biomarker of TreatmentCian M McCrudden, John W McBride, Joanne McCaffrey, et al.
Cancer Nanotechnology|June 15, 2018
Gene therapy with RALA/iNOS composite nanoparticles significantly enhances survival in a model of metastatic prostate cancerCian M McCrudden, John W McBride, Joanne McCaffrey, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 17, 2016
DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedlesAhlam A Ali, Cian M McCrudden, Joanne McCaffrey, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|March 7, 2018
DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle systemGrace Cole, Ahlam A Ali, Cian M McCrudden, et al.
Vaccine|February 25, 2012
Molecular investigations into vaginal immunization with HIV gp41 antigenic construct H4A in a quick release solid dosage formAditya Pattani, Paul F McKay, Rhonda M Curran, et al.
Pageof 2